Berkshire's Capital Question: Buybacks, a $330 Million Bet and the Target That Rose Twice
Published on 10/26/2026 at 15:42 | Editorial boerse-global.de
Berkshire Hathaway's stock finished Friday at €484.30, close to its high for the year — a level that gives added weight to a pair of analyst moves and a burst of dealmaking now drawing scrutiny from investors trying to work out what Greg Abel will do with the conglomerate's cash.
The headline number from UBS landed Thursday: analyst Brian Meredith lifted his price target on the A-shares from $906,011 to $942,405 while keeping a buy rating, citing the breadth of Berkshire's earnings base and what he regards as an attractive valuation. The same call, reported in dollar terms elsewhere, put the target at $628 versus $604 previously. Either way, the recommendation itself was left untouched. UBS expects only moderate growth in operating profit against the prior year — a forecast, not a reported figure, and a distinction that matters when the stock is already trading near its peak.
What the buybacks actually signal
Media coverage has leaned on two themes to explain the re-rating: the resumption of share repurchases and Abel's decisions on how capital gets deployed. Bloomberg reported Wednesday that investors are increasingly focused on these steps under the new leadership; CNBC framed the record levels on Saturday in similar terms. Neither account described a fresh company announcement — the story is one of shifting perception.
Roughly $4.4 billion of stock has been bought back, a figure that has been read as evidence of Abel's willingness to put money to work. A second force has been at play too: money rotating toward Berkshire while shares of AI chipmakers lost ground. That distinction is worth holding onto. Buybacks say something about how the company spends its own capital; reallocation by other investors explains part of the demand for the stock. Both can support the price, but they tell you different things about the business.
Should investors sell immediately? Or is it worth buying Berkshire Hathaway?
Bending Spoons: a $330 million commitment, with strings
The clearest example of capital going out the door is the additional stake in Bending Spoons agreed on October 14. Berkshire committed a further $330 million through a private placement, a move that would lift its holding to 4% once the transaction closes. The mechanics: 10 million ordinary shares priced at $33.00 each. Bending Spoons said the proceeds are meant to strengthen its financial flexibility and fund acquisitions.
That conditionality is the crux. The larger stake depends on completion, so the agreement is not the same as a finished top-up — and it should not be billed as the proven trigger for Berkshire's record run. The investment is designed to give the portfolio company room to maneuver; it does not by itself guarantee a return for Berkshire. What matters is how successfully Bending Spoons deploys the money.
Poland, and the wider map
Expansion is not confined to the investment book. Berkshire Hathaway Specialty Insurance announced on October 19 that it is entering the Polish market, naming Carsten Keune as country manager for Poland with responsibility for business across Central and Eastern Europe.
Berkshire Hathaway at a turning point? This analysis reveals what investors need to know now.
Taken together, the pieces form a coherent picture behind the higher analyst marks: capital committed to a private company, billions returned to shareholders, and a geographic push in insurance. None of it substitutes for proof of results. The question investors keep circling back to is whether these moves — the stake, the buybacks, the new market — translate into lasting economic value.
Ad
Berkshire Hathaway Stock: New Analysis - 26 October
Fresh Berkshire Hathaway information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
